Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Rodríguez-Blanco, G; Burgers, PC; Dekker, LJ; Ijzermans, JJ; Wildhagen, MF; Schenk-Braat, EA; Bangma, CH; Jenster, G; Luider, TM.
Serum levels of arachidonic acid metabolites change during prostate cancer progression.
Prostate. 2014; 74(6): 618-27. Doi: 10.1002/pros.22779
Web of Science PubMed FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz
Rodriguez Blanco Giovanny
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
BACKGROUND: Arachidonic acid (AA) pathway has been shown to play a role in the development and progression of prostate cancer (PCa). In this study we aimed to assess the changes in concentrations of hydroxyeicosatetraenoic acids (HETEs) in serum samples from patients diagnosed with PCa compared to controls. METHODS: HETEs were determined using ultrahigh pressure liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS). RESULTS: Elevated concentrations of 5-HETE, 8-HETE, 11-HETE and 15-HETE were observed in 6 out of 20 patients diagnosed with PCa; no statistical differences with controls were observed for 12-HETE and AA in the discovery set. An independent validation set composed of 222 samples divided in five groups ranging from subjects with low PSA and no PCa, to patients with advanced PCa was included. In 30% of the patients in the advanced PCa group, up to ten times higher concentrations of the same set of HETEs were observed with a significant concomitant decrease of the concentration of AA. Logistic regression and Kaplan-Meier curves illustrate that a decreased concentration of AA is a predictor of PCa biochemical recurrence after radical prostatectomy (RP). CONCLUSIONS: From the present study we conclude that a significant association between AA and AA metabolites in serum and PCa progression exists, although serum concentrations of HETEs exhibited low sensitivity toward the diagnosis of PCa.
Find related publications in this database (using NLM MeSH Indexing)
Aged - administration & dosage
Arachidonic Acid - metabolism
Chromatography, High Pressure Liquid - administration & dosage
Disease Progression - administration & dosage
Humans - administration & dosage
Hydroxyeicosatetraenoic Acids - blood
Male - administration & dosage
Middle Aged - administration & dosage
Prostate - metabolism
Prostatic Neoplasms - blood, pathology
Tandem Mass Spectrometry - administration & dosage

Find related publications in this database (Keywords)
mass spectrometry
UHPLC
biomarker
HETEs
arachidonic acid
prostate cancer
© Med Uni Graz Impressum